Gennaro Riccio
Overview
Explore the profile of Gennaro Riccio including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
33
Citations
555
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
11.
Sommella E, Badolati N, Riccio G, Salviati E, Bottone S, Dentice M, et al.
Nutrients
. 2019 Jan;
11(1).
PMID: 30646510
Reduction in cholesterol blood levels represents one of the therapeutic goals to achieve in order to reduce the occurrence of cardiovascular diseases. Commonly, this goal is attempted by promoting healthy...
12.
T-cell Activating Tribodies as a Novel Approach for Efficient Killing of ErbB2-positive Cancer Cells
Riccio G, Ricardo A, Passariello M, Saraiva K, Rubino V, Cunnah P, et al.
J Immunother
. 2018 Dec;
42(1):1-10.
PMID: 30520849
The Tyrosine Kinase Receptor ErbB2 (HER2) when overexpressed in breast cancer (BC) is associated with poor prognosis. The monoclonal antibody Trastuzumab has become a standard treatment of ErbB2+BC. The antibody...
13.
Riccio G, Sommella E, Badolati N, Salviati E, Bottone S, Campiglia P, et al.
Nutrients
. 2018 Nov;
10(11).
PMID: 30463345
Chemotherapy-induced alopecia (CIA) is a common side effect of conventional chemotherapy and represents a major problem in clinical oncology. Even months after the end of chemotherapy, many cancer patients complain...
14.
Badolati N, Sommella E, Riccio G, Salviati E, Heintz D, Bottone S, et al.
Nutrients
. 2018 Oct;
10(10).
PMID: 30279339
Patterned hair loss (PHL) affects around 50% of the adult population worldwide. The negative impact that this condition exerts on people's life quality has boosted the appearance of over-the-counter products...
15.
De Lorenzo C, Paciello R, Riccio G, Rea D, Barbieri A, Coppola C, et al.
Onco Targets Ther
. 2018 May;
11:2241-2250.
PMID: 29719406
Purpose: Pertuzumab, a novel anti-epidermal growth factor receptor 2 humanized monoclonal antibody, and trastuzumab-emtansine (TDM1), a novel antibody-drug conjugate made up of trastuzumab covalently linked to the highly potent microtubule...
16.
Riccio G, Antonucci S, Coppola C, DAvino C, Piscopo G, Fiore D, et al.
Front Physiol
. 2018 Feb;
9:38.
PMID: 29467663
The ErbB2 blocker trastuzumab improves survival in oncologic patients, but can cause cardiotoxicity. The late Na+ current inhibitor ranolazine has been shown to counter experimental HF, including doxorubicin cardiotoxicity (a...
17.
Riccio G, Bottone S, La Regina G, Badolati N, Passacantilli S, Rossi G, et al.
Biochemistry
. 2018 Jan;
57(5):839-851.
PMID: 29293331
The WNT pathway interconnects a network of signaling events involved in a huge plethora of cellular processes, from organogenesis to tissue homeostasis. Despite its importance, the exiguity of organic drugs...
18.
Riccio G, Maisto M, Bottone S, Badolati N, Rossi G, Tenore G, et al.
Nutrients
. 2017 Nov;
9(11).
PMID: 29156563
Inhibitors of the Wingless-related Integration site (WNT)/β-catenin pathway have recently been under consideration as potential chemopreventive agents against Familial Adenomatous Polyposis (FAP). This autosomal-dominant syndrome is caused by germline mutations...
19.
Riccio G, Da Fonseca-Ricardo A, Passariello M, Cunnah P, Mertens N, De Lorenzo C
J Immunother
. 2017 Jan;
40(4):117-128.
PMID: 28125512
Downregulation of the epidermal growth factor receptor family of receptors is improved by combining different antibodies to noncompetitive epitopes. For ErbB2/HER2 this has already been translated into clinical practice by...
20.
Coppola C, Riccio G, Barbieri A, Monti M, Piscopo G, Rea D, et al.
Onco Targets Ther
. 2016 Nov;
9:6785-6794.
PMID: 27843329
Objective: Considering that global left ventricular systolic radial strain is a sensitive technique for the early detection of left ventricular dysfunction due to antineoplastics and the analysis of segmental myocardial...